Volume 5, number 2
 Views: (Visited 293 times, 1 visits today)    PDF Downloads: 936

Nwagha I. U, The Clinical Utility of Early Follicular Phase Lh/Fsh Ratio as a Presumptive Evidence of Ovulation in the Management of Infertile Women in Enugu, Nigeria. Biosci Biotechnol Res Asia 2008;5(2)
Manuscript received on : October 02, 2008
Manuscript accepted on : November 08, 2008
Published online on:  12-03-2016
How to Cite    |   Publication History    |   PlumX Article Matrix

The Clinical Utility of Early Follicular Phase Lh/Fsh Ratio as  a Presumptive Evidence of Ovulation in the Management of Infertile Women in Enugu, Nigeria

I. U. Nwagha

Department of Physiology/Obstetrics and Gynecology, College of Medicine, University of Nigeria, Enugu Campus, Nigeria.

ABSTRACT: Follicular maturation is initiated by follicle stimulating hormone (Fsh) and later assisted by luteinizing hormone (Lh).In the early phase of follicular maturation, the concentration of these hormones is in a particular equilibrium that ensures adequate ovulation. The extent of ovulatory dysfunction that will occur when this equilibrium is altered is variable. The objective of the study was to determine whether early follicular phase Lh/Fsh ratio can be used as a presumptive evidence of ovulation in a resource limited setting. This is a cross sectional study involving 110 women undergoing infertility treatment in Enugu between January 2007 and June 2008.Early follicular phase Fsh, Lh and midluteal phase progesterone was assayed using standard methods. The data was analyzed by descriptive and inferential statistics using the statistical package SPSS for windows version 13. Twenty six women (23.6%) had Lh/Fsh ratio of less than one with a mean progesterone of 10.2±2.4 ng/ml.Twenty two (20%) had Lh/Fsh ratio of 1-2 with mean progesterone of 13.9±3.4ng/ml.Majority, sixty two (56.4%) had Lh/Fsh ratio of more than 2, with mean progesterone of 5.5±1.5ng/ml.There is a statistically significant difference between Lh/Fsh ratios and the levels of progesterone (F = 13.169,P=000).Early follicular phase Lh/Fsh ratio of more than two may indicate anovulation.Thus in a resource limited setting, treatment can be instituted without recourse for further expensive investigation.

KEYWORDS: Lh/Fsh ratio; Infertility; Anovulation; Resource limited setting

Download this article as: 
Copy the following to cite this article:

Nwagha I. U, The Clinical Utility of Early Follicular Phase Lh/Fsh Ratio as a Presumptive Evidence of Ovulation in the Management of Infertile Women in Enugu, Nigeria. Biosci Biotechnol Res Asia 2008;5(2)

Copy the following to cite this URL:

Nwagha I. U, The Clinical Utility of Early Follicular Phase Lh/Fsh Ratio as a Presumptive Evidence of Ovulation in the Management of Infertile Women in Enugu, Nigeria. Biosci Biotechnol Res Asia 2008;5(2). Available from: https://www.biotech-asia.org/?p=7184

Introduction           

Infertility has remained a significant factor that determines the cordiality between married couples in our environment. Childlessness brings unhappiness and unfulfilled dreams; more so in settings where great importance is attached to child bearing. It is very common, occurring in about 1 in every 10 couple’s worldwide1. The prevalence is particularly high in sub-Saharan Africa, ranging from 20-40% in some parts of West Africa1 and between 36.7% and 63.3% in Nigeria2.

Infertility in the female, which constitute between 30% and 48% of cases 3,4,   could result from ovulatory dysfunction, abnormalities of the cervix, uterus and tubes5,6. In the Western countries, inability to ovulate occurs in approximately 20% of infertile women7 while it is approximately 25% in most centers in sub-Saharan Africa4. Ovulatory dysfunction results commonly from polycystic ovarian syndrome (PCOS) accounting for 70% of cases7. Less common causes include, hypogonadotropic hypogonadism, hyperprolactinaemia and premature ovarian failure (hypergonadotropic hypogonadism)7.

The natural process that occurs during ovulation is regulated by the complex interplay of hypothalamic,pituitary and ovarian hormones. The hypothalamus produces the gonadotropin releasing hormone (GnRh), which stimulates the pituitary to produce follicle stimulating hormone (Fsh) and luteinizing hormone (Lh).These hormones are responsible for development and growth of Graffian follicles and indeed ovulation. Serum Fsh and Lh are at their lowest levels just before the start of follicular phase. In the early follicular phase, the level of Fsh begins to rise but the rise in Lh begins later and continues slowly and steadily. At this stage therefore Fsh is either higher or at the same level as Lh.The maintenance of normal Fsh to Lh ratio at this point is necessary in the determination of adequate follicular maturation and ovulation. Indeed some studies have highlighted that early follicular phase Fsh/Lh ratio can be used as a significant indicator for follicular maturation both for natural and stimulated cycles8,9,10. Furthermore, abnormal Fsh/Lh ratio has also been implicated in unexplained recurrent pregnancy loss11.

Prior to the introduction of hormone assay facilities in our environment, diagnosis of ovulatory dysfunction was made by histological examination of a 21 day endometrial biopsy. Currently this has largely been replaced by assay of reproductive hormones whose cost can hardly be afforded by an average Nigerian. This makes the management of infertility in a resource limited setting very frustrating to the gynaecologist.

The serum levels of some reproductive hormones; early follicular phase Fsh,Lh and mid-luteal phase progesterone determine the ovulatory functions and thus cyclical changes that occur in the endometrium.Studies have shown that a rise in the midluteal phase progesterone of  more than 10ng/ml is a presumptive evidence  of ovulation12-15.

In this study therefore we decided to find out whether there is any relationship between early follicular phase Fsh/Lh ratio and mid-luteal phase progesterone as a presumptive evidence for ovulation.

Subjects and Methods

Patient Characteristics

This is a cross sectional study involving 110 apparently normal women aged between 20-40years.They are being managed for infertility between January 2007 and June 2008 and were recruited from the university of Nigeria Teaching Hospital, Enugu and some private hospitals in Enugu and environs. Ethical approval was obtained from the relevant local authority and oral consent was obtained from the subjects.

Inclusion criteria were normal tubal patency test, normal uterus and cervix, normal male fertility test and normal menstrual cycle. Those with BMI more than   30 kg/m2 were excluded. Very high Lh and Fsh level of 35miu/ml or more were not included in the analysis .This was to avoid subjects tending towards premature ovarian failure. Subjects that met the above criteria were recruited and some reproductive hormones assayed.

Laboratory Methods

The investigations were done at Amblin laboratories Enugu.  Amblin was chosen because the laboratory is one of the first that started hormone assay in South East Nigeria; no doubt many gynaecologists in the region patronize them. They have good quality control which ensures the production of standardized results.

Fasting blood samples were taken on day three of the menstrual cycle for the measurement of Fsh and Lh while the samples for progesterone were taken at the midluteal phase (day 21 of the menstrual cycle). For all the cases, fasting venous blood was collected from the antecubital vein into sterile plain bottles. Samples were allowed to stand for about 30 minutes to clot and then centrifuged at 3,500 rpm for ten minutes.  Serum samples were analyzed within three days of sample collection using the Microwell immunoassay kit, SYNTRON Bioresearch incorporated USA.Samples not analyzed immediately were refrigerated at a temperature of 2-8 degrees centigrade.

FSH assay

For precision, the intra-assay coefficient of variation (C.V) was 7.5 % while the inter-assay C.V was 5.6% .The sensitivity was less than 1.95mIU/ml. The early follicular phase reference range used was 3-20 mIU/ml standardized against World Health Organization 2nd international reference preparation (IRP) 94/632(78/549).

LH assay

The intra-assay coefficient of variation (C.V) was 5.5% and while the inter- assay C.V was 6.3%.The sensitivity was 5.5mIU/ml. The early follicular phase reference range used was 5-20 mIU/ml standardized against World Health Organization 1st international reference preparation (IRP) 68/40.

Progesterone assay

The intra-assay coefficient of variation (C.V) was  5.7%   while the inter- assay C.V was  6.7% .The sensitivity is 0.1ng/ml. The luteal phase reference range used was 2.5-32ng/ml with a cross-reactivity of less than 0.8% with all major steroid hormones.

Statistical Analysis

This was done using the statistical package SPSS for windows version 13.  Results were presented as mean and standard deviation. The Lh/Fsh ratios were calculated and the findings were used to group subjects into three; a) Lh/Fsh ratios less than one,b) Lh/Fsh ratios between one and two,c) Lh/Fsh ratios of  more than two. The mean Lh,Fsh and  progesterone values was calculated for each group. Test for significant was done using Anova and values less than or equal to 0.05 were considered significant.

Results

The age range of the patients was 20 to 40 years, with a mean age of 29.9 ±3.4years. The minimum parity was 0 while the maximum parity was 2. Primary infertility occurred in 30.2%, while 69.8% had secondary infertility. Twenty six (23.6%) had Lh/Fsh ratio of less than one with a mean Lh of 3.2±0.6miu/ml,Fsh of 5.9±1.8miu/ml and progesterone of 10.2±2.4 ng/ml.Twenty two (20%) had Lh/Fsh ratio of 1-2 with mean Lh of 11.2±3.6 miu/ml,Fsh of 5.8± 1.8 miu/ml and progesterone of 13.9±3.4ng/ml.Majority,sixty two (56.4%) had Lh/Fsh ratio of more than 2 ,with mean Lh of 24.3±8.2 miu/ml,Fsh of 10.2±2.9 miu/ml and a progesterone of 5.5±1.5ng/ml.There is a statistically significant difference between Lh/Fsh ratios and the levels of progesterone (F = 13.169,P=000).These findings are illustrated in the table presented. 

Discussion

In this study, prevalence of Lh/Fsh ratio of more than two was higher than the ratios of less than two. This was also the situation in a previous study where we recorded a high prevalence of elevated Lh/Fsh ratio16.We also observed that there was an inverse relationship between the level of progesterone and the Lh/Fsh ratio, with the progesterone levels lowest in the group that had the highest Lh/Fsh ratio. The mean progesterone level in  the group with Lh/Fsh ratio of more than two is in the non ovulatory range. Further more, the same group of subjects with high Lh/Fsh ratio had an average Fsh of more than 10 miu/ml.This situation has been proved to be   an indication of poor ovarian reserve and difficulty in stimulation17,18.Although it has been widely believed that the early follicular phase Fsh drawn on day 3 of menstrual cycle has a normal ranges of  about 3-20 miu/ml,the absolute levels have often been used as a gauge of ovarian reserve. In general, under 6 is excellent, 6-9 is good, 9-10 fair, 10-13 is diminished reserve and, 13+ very hard to stimulate. Indeed studies have shown that a single Fsh determination of 10 miu/mL on the 3rd day of the cycle for the prediction of a poor ovarian response showed 87% sensitivity and, 100% specificity19

The utilization of Lh/Fsh ratio for the diagnosis of polycystic ovarian disease has been a subject of controversy. Although the incidence of elevated Lh/Fsh ratio in PCOS is high20,the utilization of this singular parameter in diagnosis is still a subject of controversy. Previously some authors believed strongly in  this phenomenon21,22  However ,more recent studies have continued to query its significance in diagnosis20,,23,24.Generally speaking, the ratio is usually close to 1:1,and any thing higher than 2 is accepted as abnormal20,and may be one possible though not conclusive indication of PCOS.

In this study we have been able to show that abnormal Lh /Fsh ratio of more than two was associated with low progesterone level. Studies have shown that progesterone levels in this range may indicate anovulation12-15. While taking these arguments into consideration, we should consider the peculiar socioeconomic conditions of our environment .Most of our people cannot afford the cost of infertility investigation and treatment. The most important consideration here should be that since we have established a relationship between high Lh/Fsh ratio to anovulatory levels of progesterone, the issue of whether this is as a result of PCOS should be a matter of academic exercise and arguments should be reserved for further studies. We therefore advocate initiation of treatment for anovulation in our poor socioeconomic environment when early follicular phase Lh/Fsh ratio is more than two. Further studies should aim at tracking the follicles of these subjects with elevated Lh/Fsh ratio to determine whether ovulation occurred or not. The subjects should also be followed up to determine pregnancy rates and outcome.

 Polycystic ovarian syndrome, hyperprolactinaemia, anovulation and defective luteal function are common endocrine disorders that plague our infertile women. Hormone assay, though a significant tool in contemporary management of infertility has remained unaffordable by most of our subjects. If a proactive action is not taken, it will continue to hinder our efforts towards providing optimal infertility care. Reproductive endocrinology is yet to be fully developed in our environment and until this is done, diagnosis and treatment of ovulatory dysfunction should as a matter of fact involve basic modifications to suite our peculiar socioeconomic circumstances16.

Tables 1: Average values for Lh/Fsh ratio and progesterone.

Lh/Fsh ratio Lh(miu/ml) Fsh(miu/ml) Progesterone(ng/ml)
< 1(n=26) 23.6% 3.2±0.6 5.9±1.8

 

 

10.2±2.4
1-2(n=22) 20% 11.2±3.6

.

 

5.8±1.8 13.9±3.4
>2.(n=62)56.4% 24.3±8.2 10.2±2.9 5.5±1.5

F = 13.169,P=000

Acknowledgements

I am immensely grateful to the staff of Amblin laboratory that provided most of all the logistics. To the management, I say a big thank you for giving  significant discount for the cost of the investigations.

References

  1. Idrisa A, Kawuwa MB, Habu SA and Adebayo AA. Prolactin levels among infertile women in Maiduguri, Nigeria. Trop J Obstet Gynaecol 20(2): 97 – 100 (2003).
  2. Audu BM, Massa AA and Bukar M. Clinical presentation of infertility in Gombe, North-Eastern Nigeria. Trop J Obstet Gynaecol 20(2): 93 – 6. (2003).
  3. Garcia JE, Nelson LM, and Wallach EE. Infertility. E medicine world medical library.Available at http://www.emedicine.com/infertility. (2003).
  4. Idrisa A. Infertility In: Kwawukume EY and Emuveyan EE (eds.) Comprehensive Gynecology in the Tropics 1st edition. Graphics packaging limited, Accra. 333-45 ( 2005).
  5. Infertility. The National Women’s Health Information Centre, U.S department of health and human services. Available at http://www.health.gov/infertility  (2006).
  6. Ikechebelu JI, Adinma JIB, Ikegwuonu SG and Orie EF. Clinical Correlates of unexplained infertility in South Eastern Nigeria. Trop J Obstet Gynaecol  19(1): 8-11 ( 2002).
  7. ACOG practice bulletin. Clinical Management Guidelines for Obstetrician–gynecologists number 34,2002 Management of Infertility Caused by Ovulatory Dysfunction. Obstet Gynecol. 99(2):347-58 ( 2002) .
  8. Ho JY, Guu HF, Yi YC,  Chen MJ and  Ho ES. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict “low responders”Fertil Steril 83(4): 883-88 ( 2005).
  9. Mukherjee, T, Copperman A, Lapiinski R et al., An elevated day three follicle-stimulating hormone:luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil Steril 65: 588–93 ( 1996).
  10. Barroso G,Oehninger S,Monzo A, Kolm M P,Gibbons WE, Muasher S J. High FSH:LH ratio and low LH levels in basal cycle day 3 : Impact on follicular development and IVF outcome. Journal of Assisted Reproduction and Genetics  18(9): 499-505 ( 2001).
  11. Gürbüz B,Yalti S, Ozden S and  Ficicioglu C, High basal estradiol level and FSH/LH ratio in unexplained recurrent pregnancy loss. Archives of Gynecology and Obstetrics 278:37-9 ( 2004).
  12. Israel R, Mishell DR Jr, Stone SC, Thorneycroft IH, Moyer DL. Single luteal phase serum progesterone assay as an indicator of ovulation. Am J Obstet Gynaecol 112(8):1043-6 ( 1972).
  13. Hull MG, Savage PE, Bromham DR, Ismail AA, Morris AF . The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle (“ovulation”) derived form treated and untreated conception cycles.Fertil Steril 37(3):355-60 (1982).
  14. Radwanska E, Hammond J, Smith P. Single midluteal progesterone assay in the management of ovulatory infertility.J Reprod Med 26(2):85-9 ( 1981).
  15. Walling AD. Which Test Best Predicts Ovulation in infertile women? American Family Physician.Available at http://www.find Articles. Htm ( 2001)
  16.  Nwagha UI,Obiora CC,Nwagha TU,Anyaehie UB,Igwe JC,Aronu C. Endocrine assessment of non-obese infertile females in a developing economy. Biosciences, Biotechnology Research Asia 5(1): 145-50 (2008)
  17. Van der Stege JG,Linden PJQ. Useful Predictors of Ovarian Stimulation Response in Women Undergoing in vitro Fertilization. Gynecol Obstet Invest 52:43-6 ( 2001).
  18. Mayorga MP, Gromoll J, Behre HM, Gassner C, Nieschlag E and  Simoni M. Ovarian Response to Follicle-Stimulating Hormone (FSH) Stimulation Depends on the FSH Receptor Genotype. The Journal of Clinical Endocrinology & Metabolism 85( 9): 3365-69 ( 2000).
  19. Franco RC, Ferriani RA, Moura MD et al. Evaluation of Ovarian Reserve: Comparison Between Basal FSH Level and Clomiphene Test. Rev Bras Ginecol Obstet 24(5):323-27 ( 2002).
  20. Banaszewska B, Spaczyński RZ, Pelesz M, Pawelczyk L
  21. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia. Rocz Akad Med Bialymst 48:131-4 ( 2003).
  22. Scheele F, Hompes PGA, Van der Meer M, Schoute E, Schoemaker J. The effects of gonadotropin-releasing hormone agonist on treatment with low-dose follicle stimulating hormone in polycystic ovary syndrome. Human Reproduction 5: 699– 704 ( 1993).
  23. Kurioka H, Takahashi K, Irikoma M, Okada M, Ozaki T, Ueda T and  Miyazaki K. Diagnostic difficulty in polycystic ovary syndrome due to an LH-b-subunit variant. European Journal of Endocrinology 140 :235–38 (1999).
  24. Najem FI,Elmehdawi RR,and Swalem AM.Clinical and Biochemical Characteristics of Polycystic Ovary Syndrome in Benghazi- Libya:  A Retrospective study .Libyan J Med published on line AOP:080122 (2007). 
  25. Cho WL, Jayagopal V, Kilpatrick ES, Holding S and  Atkin SL. The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome. Ann Clin Biochem 43:217-19 ( 2006).
(Visited 293 times, 1 visits today)

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.